CHEMCON NSI Week ended 07 Aug 2026

Weekly Investor Report

Chemcon Speciality Chemicals Limited · Basic Materials · Specialty Chemicals

Latest close 190.1 INR
8.3% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 12.3% above the Trend Line and sits at 42.0% of its 52-week range. The latest completed week returned 8.3%, after a 3.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 40 out of 100
Latest Close 190.1 INR 7 Aug 2026
1W Return 8.3% latest completed week
4W Return 3.3% short-term follow-through
12W Return 20.0% quarterly tape
Trend Breadth 40.4% 21 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 25.09% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.3% above the Trend Line and sits at 42.0% of its 52-week range. The latest completed week returned 8.3%, after a 3.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5912-week average 0.36

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.59Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.3% over four weeks, 20.0% over 12 weeks, and -13.9% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W8.3%
4W3.3%
12W20.0%
26W9.0%
52W-13.9%
Active trend streak5 weeks
Active weeks in one year21
Trend breadth40.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.32Latest activity-pressure read.
Pressure change-69.2%Four-week change in activity pressure.
Leadership0.47Latest relative-leadership reading.
RS change118.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength43/100Blend of value, momentum, and quality. Underlying universe rank 58; rank 1 is best.
Value66/100Relative valuation strength. Underlying universe rank 35; rank 1 is best.
Quality33/100Profitability and accounting quality. Underlying universe rank 68; rank 1 is best.
Momentum25/100Medium-term price momentum. Underlying universe rank 76; rank 1 is best.
Growth37/100Revenue and earnings growth. Underlying universe rank 64; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework13/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
29.5x
Price divided by trailing earnings.
Price / sales
2.9x
Market value relative to trailing revenue.
EV / EBITDA
16.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
35.0%
Gross profit retained from each unit of revenue.
Operating margin
7.8%
Operating profit retained from revenue.
Free-cash-flow margin
13.5%
Free cash flow generated from revenue.
Return on invested capital
2.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
15.7%
Latest one-year revenue growth.
EPS growth
-3.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
12.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.4%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
3.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 35 relevant articles.

7 positive · 24 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-33.4%Distance below the 52-week high.
13-week volatility6.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+12.5%Week of 22 May.
Worst week-8.5%Week of 27 Mar.
Latest week+8.3%Week of 7 Aug.

Shape of recent returns

Strong gains8
Modest gains1
Flat weeks0
Modest losses13
Sharp losses4
Recent vol6.2%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew6.0% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026190.1 INR8.3%169.3 INR221.0 INR0.320.47170.1KOn
31 Jul 2026175.5 INR-0.6%169.1 INR221.4 INR0.46-6.8160.3KOn
24 Jul 2026176.5 INR-2.7%169.9 INR222.0 INR0.70-4.3045.4KOn
17 Jul 2026181.4 INR-1.4%170.5 INR222.5 INR0.91-4.1552.5KOn
10 Jul 2026184.0 INR-1.5%171.0 INR223.0 INR1.03-2.6478.5KOn
3 Jul 2026186.9 INR-1.2%171.4 INR223.5 INR1.07-1.3620.1KOff
26 Jun 2026189.1 INR-1.8%171.6 INR224.0 INR1.240.750Off
19 Jun 2026192.6 INR-1.2%172.5 INR224.5 INR1.392.8648.6KOff
12 Jun 2026194.9 INR-6.2%173.1 INR225.0 INR1.496.0037.1KOff
5 Jun 2026207.9 INR11.5%174.3 INR225.4 INR1.3514.443.5MOff
29 May 2026186.5 INR4.6%175.0 INR225.8 INR1.252.15667.2KOff
22 May 2026178.3 INR12.5%176.7 INR226.2 INR0.92-3.00791.8KOff
15 May 2026158.4 INR-8.3%178.8 INR226.9 INR0.53-13.58189.9KOff
8 May 2026172.8 INR11.0%182.0 INR227.5 INR0.43-8.12381.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context